Chrysin prevents inflammation-coinciding liver steatosis via AMPK signalling.
Chuanyue GaoHuan ZhangLulin NieKaiwu HePeimao LiXingxing WangZaijun ZhangYongmei XieShupeng LiGongping LiuXinfeng HuangHuiping DengJianjun LiuXi-Fei YangPublished in: The Journal of pharmacy and pharmacology (2023)
In summary, CN treatment reduced lipid metabolism by AMPK and inflammasome activation by NLRP3 inhibition, ultimately improving NAFLD progression. These findings suggest that CN could be a potential treatment candidate for the NFLAD condition.